Science Signaling · 2009 · 186 citations · 61 references
Life SciencesImmunologyMolecular BiologyCell SignalingInflammationInnate ImmunityInflammatory ProcessesInflammatory SignalingInnate Immune ModulationInnate Immune Signaling PathwaysMacrophage BiologyToll-like ReceptorsAnti-inflammatory Signaling PathwaysCyclic Adenosine Monophosphate PathwayCyclic Adenosine Monophosphate SignalingMacrophage Signaling PathwaysPka ModulationPro-inflammatory Signaling PathwaysToll-like Receptor SignalingToll-like Receptor Signaling Pathways
The activation of macrophages through Toll-like receptor (TLR) pathways leads to the production of a broad array of cytokines and mediators that coordinate the immune response. The inflammatory potential of this response can be reduced by compounds, such as prostaglandin E(2), that induce the production of cyclic adenosine monophosphate (cAMP). Through experiments with cAMP analogs and multigene RNA interference (RNAi), we showed that key anti-inflammatory effects of cAMP were mediated specifically by cAMP-dependent protein kinase (PKA). Selective inhibitors of PKA anchoring, time-lapse microscopy, and RNAi screening suggested that differential mechanisms of PKA action existed. We showed a specific role for A kinase-anchoring protein 95 in suppressing the expression of the gene encoding tumor necrosis factor-alpha, which involved phosphorylation of p105 (also known as Nfkb1) by PKA at a site adjacent to the region targeted by inhibitor of nuclear factor kappaB kinases. These data suggest that crosstalk between the TLR4 and cAMP pathways in macrophages can be coordinated through PKA-dependent scaffolds that localize specific pools of the kinase to distinct substrates.
61
Specificity and mechanism of action of some commonly used protein kinase inhibitors
Stephen Davies, Helen Reddy, Matilde Caivano et al. · Biochemical Journal · 2000 · 4.1K citations · Full text
Specificity and mechanism of action of some commonly used protein kinase inhibitors
Stephen Davies, Helen Reddy, Matilde Caivano et al. · Biochemical Journal · 2000 · 3.1K citations
IκB: a Specific Inhibitor of the NF-κB Transcription Factor
Patrick A. Baeuerle, David Baltimore · Science · 1988 · 2.2K citations